Dr. Max reports 20% revenue growth

In the ranking of market leaders in the European pharmaceutical sector, Dr. Max Group has solidified its position as the second largest pharmacy network on the continent, recording an annual growth of 20%, with revenues of 4.6 billion euros in 2023. The figures underscore the brand’s growing presence and popularity among consumers, through successful expansion into various European markets, including the Czech Republic, Romania, Slovakia, Poland, Serbia, and ...

Developed by Codecraftsman